T1	B-Protein	B-Protein	0	4	ETS1	ETS1	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	4	5	,	,	I-NP	,	O	5	P	O
T14	B-Entity	B-Entity	6	14	NFkappaB	NFkappaB	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	15	18	and	and	I-NP	CC	O	5	NMOD	O
T15	B-Entity	B-Entity	19	22	AP1	AP1	I-NP	NN	B-protein	7	SUB	B-protein
O	O	O	23	38	synergistically	synergistically	B-ADVP	RB	O	7	VMOD	O
O	O	O	39	52	transactivate	transactivate	B-VP	VBP	O	0	ROOT	O
O	O	O	53	56	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	57	62	human	human	I-NP	JJ	B-DNA	13	NMOD	B-DNA
T2	B-Protein	B-Protein	63	65	GM	GM	I-NP	NNP	I-DNA	13	NMOD	I-DNA
T2	I-Protein	I-Protein	65	66	-	-	I-NP	HYPH	I-DNA	13	NMOD	I-DNA
T2	I-Protein	I-Protein	66	69	CSF	CSF	I-NP	NN	I-DNA	13	NMOD	I-DNA
T16	B-Entity	B-Entity	70	78	promoter	promoter	I-NP	NN	I-DNA	7	OBJ	I-DNA
O	O	O	78	79	.	.	O	.	O	7	P	O

O	O	O	81	91	Activation	Activation	B-NP	NN	O	6	SUB	O
O	O	O	92	94	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	95	101	helper	helper	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	O	102	103	T	T	I-NP	NN	I-cell_type	5	NMOD	I-cell_type
O	O	O	104	109	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	110	117	results	result	B-VP	VBZ	O	0	ROOT	O
O	O	O	118	120	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	121	131	coordinate	coordinate	B-NP	JJ	O	9	NMOD	O
O	O	O	132	142	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	O	143	145	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	146	147	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	148	154	number	number	I-NP	NN	O	10	PMOD	O
O	O	O	155	157	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	158	167	cytokines	cytokine	B-NP	NNS	B-protein	13	PMOD	B-protein
O	O	O	168	176	involved	involve	B-VP	VBN	O	14	NMOD	O
O	O	O	177	179	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	180	195	differentiation	differentiation	B-NP	NN	O	21	NMOD	O
O	O	O	195	196	,	,	O	,	O	21	P	O
O	O	O	197	210	proliferation	proliferation	B-NP	NN	O	21	NMOD	O
O	O	O	211	214	and	and	O	CC	O	21	NMOD	O
O	O	O	215	225	activation	activation	B-NP	NN	O	16	PMOD	O
O	O	O	226	228	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	229	232	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	233	247	haematopoietic	haematopoietic	I-NP	JJ	O	25	NMOD	O
O	O	O	248	254	system	system	I-NP	NN	O	22	PMOD	O
O	O	O	254	255	.	.	O	.	O	6	P	O

T3	B-Protein	B-Protein	256	267	Granulocyte	Granulocyte	B-NP	NN	B-protein	6	NMOD	B-protein
T3	I-Protein	I-Protein	267	268	-	-	I-NP	HYPH	I-protein	6	NMOD	I-protein
T3	I-Protein	I-Protein	268	278	macrophage	macrophage	I-NP	NN	I-protein	6	NMOD	I-protein
T3	I-Protein	I-Protein	279	285	colony	colony	I-NP	NN	I-protein	6	NMOD	I-protein
T3	I-Protein	I-Protein	286	297	stimulating	stimulating	I-NP	NN	I-protein	6	NMOD	I-protein
T3	I-Protein	I-Protein	298	304	factor	factor	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	305	306	(	(	O	(	O	11	DEP	O
T4	B-Protein	B-Protein	306	308	GM	GM	B-NP	NN	B-protein	10	NMOD	B-protein
T4	I-Protein	I-Protein	308	309	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T4	I-Protein	I-Protein	309	312	CSF	CSF	I-NP	NN	I-protein	11	DEP	I-protein
O	O	O	312	313	)	)	O	)	O	6	NMOD	O
O	O	O	314	316	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	317	320	one	one	B-NP	CD	O	12	PRD	O
O	O	O	321	325	such	such	I-NP	JJ	O	13	NMOD	O
O	O	O	326	334	cytokine	cytokine	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	334	335	,	,	O	,	O	13	P	O
O	O	O	336	341	whose	whose	B-NP	WP$	O	19	NMOD	O
O	O	O	342	351	increased	increase	I-NP	VBN	O	19	NMOD	O
O	O	O	352	362	expression	expression	I-NP	NN	O	13	NMOD	O
O	O	O	363	370	results	result	B-VP	VBZ	O	19	SBAR	O
O	O	O	371	377	mostly	mostly	B-ADVP	RB	O	22	PMOD	O
O	O	O	378	382	from	from	B-PP	IN	O	20	VMOD	O
O	O	O	383	392	increases	increase	B-NP	NNS	O	22	PMOD	O
O	O	O	393	395	in	in	B-PP	IN	O	23	NMOD	O
O	O	O	396	409	transcription	transcription	B-NP	NN	O	24	PMOD	O
O	O	O	409	410	.	.	O	.	O	12	P	O

T17	B-Entity	B-Entity	411	414	Cis	Cis	B-NP	NN	B-protein	4	NMOD	B-protein
T17	I-Entity	I-Entity	414	415	-	-	O	HYPH	O	1	P	O
T17	I-Entity	I-Entity	415	421	acting	act	B-VP	VBG	O	4	NMOD	O
T17	I-Entity	I-Entity	422	430	elements	element	B-NP	NNS	O	15	SUB	O
O	O	O	431	435	with	with	B-PP	IN	O	4	NMOD	O
O	O	O	436	444	NFkappaB	NFkappaB	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	444	445	,	,	I-NP	,	O	10	P	O
O	O	O	446	449	AP1	AP1	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	450	453	and	and	I-NP	CC	O	10	NMOD	O
O	O	O	454	457	ETS	ETS	I-NP	NN	B-protein	14	NMOD	B-protein
T18	B-Entity	B-Entity	457	458	-	-	O	HYPH	O	14	NMOD	O
T18	I-Entity	I-Entity	458	462	like	like	B-NP	JJ	O	14	NMOD	O
T18	I-Entity	I-Entity	463	470	binding	bind	I-NP	VBG	O	14	NMOD	O
T18	I-Entity	I-Entity	471	477	motifs	motif	I-NP	NNS	O	5	PMOD	O
O	O	O	478	482	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	483	487	been	be	I-VP	VBN	O	15	VC	O
O	O	O	488	498	identified	identify	I-VP	VBN	O	16	VC	O
O	O	O	499	501	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	502	505	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	506	514	promoter	promoter	I-NP	NN	B-DNA	21	NMOD	B-DNA
O	O	O	515	521	region	region	I-NP	NN	I-DNA	18	PMOD	I-DNA
O	O	O	522	524	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	525	528	the	the	B-NP	DT	O	27	NMOD	O
T5	B-Protein	B-Protein	529	531	GM	GM	I-NP	NNP	O	27	NMOD	O
T5	I-Protein	I-Protein	531	532	-	-	I-NP	HYPH	O	27	NMOD	O
T5	I-Protein	I-Protein	532	535	CSF	CSF	I-NP	NN	B-DNA	27	NMOD	B-DNA
O	O	O	536	540	gene	gene	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	O	540	541	,	,	O	,	O	15	P	O
O	O	O	542	545	and	and	O	CC	O	15	VMOD	O
O	O	O	546	549	are	be	B-VP	VBP	O	15	VMOD	O
O	O	O	550	559	important	important	B-ADJP	JJ	O	33	AMOD	O
O	O	O	560	562	or	or	I-ADJP	CC	O	33	AMOD	O
O	O	O	563	572	essential	essential	I-ADJP	JJ	O	30	PRD	O
O	O	O	573	576	for	for	B-PP	IN	O	33	AMOD	O
O	O	O	577	592	transcriptional	transcriptional	B-NP	JJ	O	36	NMOD	O
O	O	O	593	601	activity	activity	I-NP	NN	O	34	PMOD	O
O	O	O	602	611	following	follow	B-PP	VBG	O	36	NMOD	O
O	O	O	612	613	T	T	B-NP	NN	O	40	NMOD	O
O	O	O	614	618	cell	cell	I-NP	NN	O	40	NMOD	O
O	O	O	619	629	activation	activation	I-NP	NN	O	37	PMOD	O
O	O	O	629	630	.	.	O	.	O	15	P	O

T6	B-Protein	B-Protein	631	635	ETS1	ETS1	B-NP	NN	B-protein	2	SUB	B-protein
O	O	O	636	638	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	639	640	a	a	B-NP	DT	O	5	NMOD	O
O	O	O	641	654	transcription	transcription	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	655	661	factor	factor	I-NP	NN	I-protein	2	PRD	I-protein
O	O	O	662	664	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	665	668	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	669	672	ETS	ETS	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	673	679	family	family	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	680	684	that	that	B-NP	WDT	O	5	NMOD	O
O	O	O	685	687	is	be	B-VP	VBZ	O	10	SBAR	O
O	O	O	688	697	expressed	express	I-VP	VBN	O	11	VC	O
O	O	O	698	700	in	in	B-PP	IN	O	12	VMOD	O
O	O	O	701	702	T	T	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	O	703	708	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	708	709	.	.	O	.	O	2	P	O

O	O	O	710	712	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	713	717	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	718	728	previously	previously	I-VP	RB	O	2	VMOD	O
O	O	O	729	734	shown	show	I-VP	VBN	O	2	VC	O
O	O	O	735	739	that	that	B-SBAR	IN	O	4	VMOD	O
T7	B-Protein	B-Protein	740	744	ETS1	ETS1	B-NP	NN	B-protein	7	SUB	B-protein
O	O	O	745	748	can	can	B-VP	MD	O	5	SBAR	O
O	O	O	749	762	transactivate	transactivate	I-VP	VB	O	7	VC	O
T8	B-Protein	B-Protein	763	765	GM	GM	B-NP	NNP	O	11	NMOD	O
T8	I-Protein	I-Protein	765	766	-	-	B-NP	HYPH	O	11	NMOD	O
T8	I-Protein	I-Protein	766	769	CSF	CSF	I-NP	NN	B-protein	8	OBJ	B-protein
O	O	O	770	772	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	773	779	Jurkat	Jurkat	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	O	780	781	T	T	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	782	787	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	787	788	,	,	O	,	O	7	P	O
O	O	O	789	792	but	but	O	CC	O	7	VMOD	O
O	O	O	793	797	only	only	B-SBAR	RB	O	19	DEP	O
O	O	O	798	803	after	after	I-SBAR	IN	O	7	VMOD	O
O	O	O	804	807	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	808	813	cells	cell	I-NP	NNS	O	19	SUB	O
O	O	O	814	818	have	have	B-VP	VBP	O	19	DEP	O
O	O	O	819	823	been	be	I-VP	VBN	O	22	VC	O
O	O	O	824	834	stimulated	stimulate	I-VP	VBN	O	23	VC	O
O	O	O	835	837	by	by	B-PP	IN	O	24	VMOD	O
O	O	O	838	847	treatment	treatment	B-NP	NN	O	25	PMOD	O
O	O	O	848	852	with	with	B-PP	IN	O	26	NMOD	O
O	O	O	853	856	PMA	PMA	B-NP	NN	O	30	NMOD	O
O	O	O	857	860	and	and	I-NP	CC	O	30	NMOD	O
O	O	O	861	870	ionomycin	ionomycin	I-NP	NN	O	32	NMOD	O
O	O	O	870	871	,	,	O	,	O	32	P	O
O	O	O	872	878	agents	agent	B-NP	NNS	O	27	PMOD	O
O	O	O	879	883	that	that	B-NP	WDT	O	32	NMOD	O
O	O	O	884	889	mimic	mimic	B-VP	VBP	O	33	SBAR	O
O	O	O	890	891	T	T	B-NP	NN	O	37	NMOD	O
O	O	O	892	896	cell	cell	I-NP	NN	O	37	NMOD	O
O	O	O	897	907	activation	activation	I-NP	NN	O	34	OBJ	O
O	O	O	907	908	.	.	O	.	O	2	P	O

O	O	O	909	913	Thus	Thus	B-ADVP	RB	O	3	VMOD	O
O	O	O	914	916	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	917	925	proposed	propose	B-VP	VBD	O	0	ROOT	O
O	O	O	926	930	that	that	B-SBAR	IN	O	3	VMOD	O
T9	B-Protein	B-Protein	931	935	ETS1	ETS1	B-NP	NN	B-protein	15	SUB	B-protein
O	O	O	935	936	,	,	O	,	O	5	P	O
O	O	O	937	942	which	which	B-NP	WDT	O	5	NMOD	O
O	O	O	943	945	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	O	946	955	expressed	express	I-VP	VBN	O	8	VC	O
O	O	O	956	970	constitutively	constitutively	B-ADVP	RB	O	9	VMOD	O
O	O	O	971	973	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	974	980	Jurkat	Jurkat	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	O	981	986	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	O	986	987	,	,	O	,	O	5	P	O
O	O	O	988	991	may	may	B-VP	MD	O	4	SBAR	O
O	O	O	992	995	act	act	I-VP	VB	O	15	VC	O
O	O	O	996	998	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	999	1006	concert	concert	B-NP	NN	O	17	PMOD	O
O	O	O	1007	1011	with	with	B-PP	IN	O	18	NMOD	O
O	O	O	1012	1015	PMA	PMA	B-NP	NN	O	24	NMOD	O
O	O	O	1015	1016	/	/	B-NP	SYM	O	24	P	O
O	O	O	1016	1025	ionomycin	ionomycin	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	1026	1035	inducible	inducible	I-NP	JJ	I-protein	24	NMOD	I-protein
O	O	O	1036	1043	factors	factor	I-NP	NNS	I-protein	19	PMOD	I-protein
O	O	O	1043	1044	.	.	O	.	O	3	P	O

O	O	O	1045	1049	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	1050	1052	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	1053	1057	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	1058	1062	that	that	B-SBAR	IN	O	3	VMOD	O
T10	B-Protein	B-Protein	1063	1067	ETS1	ETS1	B-NP	NN	B-protein	6	SUB	B-protein
O	O	O	1068	1071	can	can	B-VP	MD	O	4	SBAR	O
O	O	O	1072	1085	transactivate	transactivate	I-VP	VB	O	6	VC	O
O	O	O	1086	1087	a	a	B-NP	DT	O	13	NMOD	O
T11	B-Protein	B-Protein	1088	1090	GM	GM	I-NP	NNP	O	13	NMOD	O
T11	I-Protein	I-Protein	1090	1091	-	-	I-NP	HYPH	O	13	NMOD	O
T11	I-Protein	I-Protein	1091	1094	CSF	CSF	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	O	1095	1103	reporter	reporter	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	O	1104	1113	construct	construct	I-NP	NN	I-DNA	7	OBJ	I-DNA
O	O	O	1114	1116	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1117	1129	unstimulated	unstimulated	B-NP	JJ	B-cell_line	17	NMOD	B-cell_line
O	O	O	1130	1136	Jurkat	Jurkat	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	O	1137	1142	cells	cell	I-NP	NNS	I-cell_line	14	PMOD	I-cell_line
O	O	O	1142	1143	,	,	O	,	O	7	P	O
O	O	O	1144	1153	providing	provide	B-VP	VBG	O	7	VMOD	O
O	O	O	1154	1158	that	that	B-SBAR	IN	O	19	PMOD	O
O	O	O	1159	1165	either	either	O	CC	O	26	NMOD	O
T19	B-Entity	B-Entity	1166	1174	NFkappaB	NFkappaB	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	1175	1177	or	or	O	CC	O	26	NMOD	O
T20	B-Entity	B-Entity	1178	1181	AP1	AP1	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	1182	1195	transcription	transcription	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	1196	1203	factors	factor	I-NP	NNS	I-protein	27	SUB	I-protein
O	O	O	1204	1207	are	be	B-VP	VBP	O	20	SBAR	O
O	O	O	1208	1216	supplied	supply	I-VP	VBN	O	27	VC	O
O	O	O	1217	1219	by	by	B-PP	IN	O	28	VMOD	O
O	O	O	1220	1222	co	co	B-NP	AFX	O	32	NMOD	O
O	O	O	1222	1223	-	-	I-NP	HYPH	O	32	NMOD	O
O	O	O	1223	1235	transfection	transfection	I-NP	NN	O	29	PMOD	O
O	O	O	1235	1236	.	.	O	.	O	3	P	O

O	O	O	1237	1239	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	1240	1247	confirm	confirm	B-VP	VBP	O	0	ROOT	O
O	O	O	1248	1252	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	1253	1260	binding	binding	B-NP	NN	O	10	SUB	O
O	O	O	1261	1263	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1264	1274	endogenous	endogenous	B-NP	JJ	O	5	PMOD	O
T21	B-Entity	B-Entity	1275	1283	NFkappaB	NFkappaB	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	1284	1287	and	and	I-NP	CC	O	6	NMOD	O
T22	B-Entity	B-Entity	1288	1291	AP1	AP1	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	1292	1294	is	be	B-VP	VBZ	O	3	SBAR	O
O	O	O	1295	1302	induced	induce	I-VP	VBN	O	10	VC	O
O	O	O	1303	1312	following	follow	B-PP	VBG	O	11	VMOD	O
O	O	O	1313	1316	PMA	PMA	B-NP	NN	O	16	NMOD	O
O	O	O	1316	1317	/	/	B-NP	SYM	O	16	NMOD	O
O	O	O	1317	1326	ionomycin	ionomycin	I-NP	NN	O	16	NMOD	O
O	O	O	1327	1336	treatment	treatment	I-NP	NN	O	12	PMOD	O
O	O	O	1337	1339	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1340	1341	T	T	B-NP	NN	B-cell_type	19	NMOD	B-cell_type
O	O	O	1342	1347	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	O	1347	1348	.	.	O	.	O	2	P	O

O	O	O	1349	1364	Transactivation	Transactivation	B-NP	NN	O	8	SUB	O
O	O	O	1365	1367	by	by	B-PP	IN	O	1	NMOD	O
T12	B-Protein	B-Protein	1368	1372	ETS1	ETS1	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	1372	1373	,	,	I-NP	,	O	7	P	O
T23	B-Entity	B-Entity	1374	1382	NFkappaB	NFkappaB	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	1383	1386	and	and	I-NP	CC	O	7	NMOD	O
T24	B-Entity	B-Entity	1387	1390	AP1	AP1	I-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	1391	1393	is	be	B-VP	VBZ	O	18	VMOD	O
O	O	O	1394	1405	synergistic	synergistic	B-ADJP	JJ	O	8	PRD	O
O	O	O	1405	1406	,	,	O	,	O	18	P	O
O	O	O	1407	1410	and	and	O	CC	O	18	VMOD	O
O	O	O	1411	1419	mutation	mutation	B-NP	NN	O	18	SUB	O
O	O	O	1420	1422	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1423	1426	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1427	1437	individual	individual	I-NP	JJ	O	17	NMOD	O
O	O	O	1438	1445	binding	bind	I-NP	VBG	O	17	NMOD	O
O	O	O	1446	1451	sites	site	I-NP	NNS	O	13	PMOD	O
O	O	O	1452	1459	reveals	reveal	B-VP	VBZ	O	0	ROOT	O
O	O	O	1460	1464	that	that	B-SBAR	IN	O	18	VMOD	O
O	O	O	1465	1468	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	1469	1484	transcriptional	transcriptional	I-NP	JJ	O	22	NMOD	O
O	O	O	1485	1495	activities	activity	I-NP	NNS	O	26	SUB	O
O	O	O	1496	1498	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	1499	1504	these	these	B-NP	DT	O	25	NMOD	O
O	O	O	1505	1512	factors	factor	I-NP	NNS	O	23	PMOD	O
O	O	O	1513	1516	are	be	B-VP	VBP	O	19	SBAR	O
O	O	O	1517	1531	interdependent	interdependent	B-ADJP	JJ	O	26	PRD	O
O	O	O	1531	1532	.	.	O	.	O	18	P	O

O	O	O	1533	1536	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1537	1544	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1545	1552	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1553	1557	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1558	1570	constitutive	constitutive	B-NP	JJ	O	9	NMOD	O
T13	B-Protein	B-Protein	1571	1575	ETS1	ETS1	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	1575	1576	,	,	O	,	O	9	P	O
O	O	O	1577	1580	and	and	O	CC	O	9	NMOD	O
O	O	O	1581	1590	inducible	inducible	B-NP	JJ	O	14	SUB	O
T25	B-Entity	B-Entity	1591	1599	NFkappaB	NFkappaB	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	1600	1603	and	and	I-NP	CC	O	9	NMOD	O
T26	B-Entity	B-Entity	1604	1607	AP1	AP1	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	1607	1608	,	,	O	,	O	9	P	O
O	O	O	1609	1618	cooperate	cooperate	B-VP	VBP	O	4	SBAR	O
O	O	O	1619	1621	as	as	B-PP	IN	O	14	VMOD	O
O	O	O	1622	1626	part	part	B-NP	NN	O	15	PMOD	O
O	O	O	1627	1629	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1630	1631	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	1632	1638	higher	high	I-NP	JJR	O	20	NMOD	O
O	O	O	1639	1644	order	order	I-NP	NN	O	22	NMOD	O
T27	B-Entity	B-Entity	1645	1660	transcriptional	transcriptional	I-NP	JJ	B-protein	22	NMOD	B-protein
T27	I-Entity	I-Entity	1661	1668	complex	complex	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	1669	1671	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	1672	1681	activated	activate	B-NP	VBN	B-cell_type	26	NMOD	B-cell_type
O	O	O	1682	1683	T	T	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	O	1684	1689	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	O	1689	1690	.	.	O	.	O	3	P	O
